Bucillamine is an antirheumatic agent classified as a mercapturic acid derivative, utilized primarily in studies for the treatment and prevention of rheumatoid arthritis and gout. By functioning as a xanthine… Read more
Bucillamine is an antirheumatic agent classified as a mercapturic acid derivative, utilized primarily in studies for the treatment and prevention of rheumatoid arthritis and gout. By functioning as a xanthine oxidase inhibitor, this compound helps reduce serum urate levels in patients suffering from hyperuricemia. The collection below includes high-quality reference standards of the Bucillamine active pharmaceutical ingredient, alongside its pharmacopeial and non-pharmacopeial impurities. Analytical laboratories rely on these reference materials for essential quality control processes, including impurity profiling and method validation during pharmaceutical development. Additionally, the availability of stable isotope labelled compounds, such as deuterated analogues, provides critical internal standards for accurate quantification in mass spectrometry and high-performance liquid chromatography applications. These research tools ensure compliance with regulatory standards by enabling precise identification and monitoring of the parent drug and its degradation products throughout the analytical lifecycle.